Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

9.30
Delayed Data
As of Oct 20
 +0.11 / +1.20%
Today’s Change
5.82
Today|||52-Week Range
9.80
+20.16%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$315.2M

Company Description

Veracyte, Inc. engages in the research, development, and commercialization of diagnostic products. Its portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Contact Information

Veracyte, Inc.
6000 Shoreline Court
South San Francisco California 94080
P:(650) 243-6300
Investor Relations:
(650) 243-6357

Employees

Shareholders

Individual stakeholders38.97%
Other institutional35.95%
Mutual fund holders19.44%

Top Executives

Bonnie H. AndersonChairman & Chief Executive Officer
Christopher M. HallPresident & Chief Operating Officer
Keith KennedyCFO & Principal Accounting Officer
Giulia C. KennedyChief Scientific Officer, SVP-Research & Product
Ashish KheterpalChief Information Officer